• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】24410

【品名】6-Fluoro-3,4-dihydro-2H-spiro[1-benzopyran-4,2'-1,3-dioxolan]-8-ol

【CA登记号】

【 分 子 式 】C11H11FO4

【 分 子 量 】226.2043432

【元素组成】C 58.41% H 4.9% F 8.4% O 28.29%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号:(II)

6-Fluoro-8-hydroxychroman-4-one (I) was converted to ethylene ketal (II) upon treatment with ethylene glycol and triethyl orthoformate, and subsequently alkylated with 1,2-dibromoethane under phase-transfer conditions to afford the bromoethyl ether (III). Wittig condensation of piperonal (V) with the (3-phthalimidopropyl)phosphonium salt (IV) in the presence of NaOMe in dioxan provided olefin (VI), which was hydrogenated over Pd/C to furnish the arylbutyl phthalimide (VII). Further deprotection of the phthalimido group of (VII) with CH3NH2 gave amine (VIII). Then, alkylation of (VIII) with bromide (III), followed by acid hydrolysis of the ketal function yielded the title compound.

1 Yasunaga, T.; Wanibuchi, F.; Yamaguchi, T.; Yamashita, H.; Kontani, T.; Tsukamoto, S.; Nomura, T.; Naito, R.; Kimura, T.; Mase, T.; Synthesis and pharmacological characterization of novel 6-fluorochroman derivatives as potential 5-HT1A receptor antagonists. J Med Chem 1998, 41, 15, 2765.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 24409 6-fluoro-8-hydroxy-2,3-dihydro-4H-chromen-4-one C9H7FO3 详情 详情
(II) 24410 6-Fluoro-3,4-dihydro-2H-spiro[1-benzopyran-4,2'-1,3-dioxolan]-8-ol C11H11FO4 详情 详情
(III) 24411 8-(2-Bromoethoxy)-6-fluoro-3,4-dihydro-2H-spiro[1-benzopyran-4,2'-1,3-dioxolane] C13H14BrFO4 详情 详情
(IV) 24412 [3-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)propyl](triphenyl)phosphonium bromide C29H25BrNO2P 详情 详情
(V) 10127 1,3-Benzodioxole-5-carbaldehyde; Heliotropine 120-57-0 C8H6O3 详情 详情
(VI) 24414 2-[(E)-4-(1,3-benzodioxol-5-yl)-3-butenyl]-1H-isoindole-1,3(2H)-dione C19H15NO4 详情 详情
(VII) 24415 2-[4-(1,3-benzodioxol-5-yl)butyl]-1H-isoindole-1,3(2H)-dione C19H17NO4 详情 详情
(VIII) 24416 4-(1,3-benzodioxol-5-yl)-1-butanamine C11H15NO2 详情 详情
Extended Information